Ziprasidone (Geodon) for schizophrenia.
出版信息
Med Lett Drugs Ther. 2001 Jun 11;43(1106):51-2.
PMID:11402259
Abstract
摘要
相似文献
1
Ziprasidone (Geodon) for schizophrenia.
Med Lett Drugs Ther. 2001 Jun 11;43(1106):51-2.
2
Focus on ziprasidone.
Curr Med Res Opin. 2001;17(2):146-50.
3
Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
J Clin Psychiatry. 2003;64 Suppl 19:3-5.
4
The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
J Clin Psychiatry. 2003;64 Suppl 19:6-12.
5
Maintaining symptom control: review of ziprasidone long-term efficacy data.
J Clin Psychiatry. 2003;64 Suppl 19:26-32.
6
Three cases of schizophrenia showing improvement after switching to blonanserin.
Psychiatry Clin Neurosci. 2011 Jun;65(4):396-7. doi: 10.1111/j.1440-1819.2011.02223.x.
7
Tolerability of ziprasidone: an expanding perspective.
J Clin Psychiatry. 2003;64 Suppl 19:40-9.
8
Ziprasidone: a new atypical antipsychotic.
Expert Opin Pharmacother. 2001 Jun;2(6):1033-42. doi: 10.1517/14656566.2.6.1033.
9
Ziprasidone: a novel psychotropic with unique properties.
Expert Rev Neurother. 2004 Mar;4(2):179-86. doi: 10.1586/14737175.4.2.179.
10
From clinical research to clinical practice: a 4-year review of ziprasidone.
CNS Spectr. 2005 Nov;10(11 Suppl 17):1-20. doi: 10.1017/s1092852900019842.
Zotero 插件